Adjuvant Radiation in Resectable Node-Positive Merkel Cell Carcinoma in the Immunotherapy Era: Implications for Future and Ongoing Trials
Open Access
Abstract
Merkel cell carcinoma (MCC) is a cutaneous malignancy often treated with surgical resection followed by adjuvant radiation therapy (RT). In the node-positive setting, adjuvant RT reduces the risk of locoregional recurrence, but historical data suggest that distant failure is a persistent issue and often fatal. This has prompted new efforts to intensify treatment in these patients with the addition of neoadjuvant or adjuvant immune checkpoint inhibitor therapy. However, newer diagnostic techniques have led to stage migration in patients with previously subclinical metastatic disease; consequently, preventing locoregional recurrence may be a higher priority in node-positive MCC patients than was previously believed. Recent trials in node-positive MCC, such as ADMEC-O, have had lower rates of adjuvant RT utilization in treatment versus control arms, which may have attenuated the observed effect of adjuvant immunotherapy. The low utilization of adjuvant RT may have also resulted in a higher recurrence rate in patients who did not have a complete response to neoadjuvant immunotherapy in the CHECKMATE 358 trial. Altogether, these are important considerations for ongoing and future immunotherapy trials in MCC and may affect the interpretation of their results. Ongoing clinical trials may determine which patients are at low risk of recurrence when treated with immunotherapy and whether adjuvant RT could be omitted in select patients.Keywords
This publication has 59 references indexed in Scilit:
- Merkel cell carcinoma: The prognostic implications of an occult primary in stage IIIB (nodal) diseaseJournal of the American Academy of Dermatology, 2012
- Merkel Cell Carcinoma of Unknown Primary OriginAnnals of Surgical Oncology, 2012
- Five Hundred Patients With Merkel Cell Carcinoma Evaluated at a Single InstitutionAnnals of Surgery, 2011
- Merkel Cell Carcinoma: 27-Year Experience at the Peter MacCallum Cancer CentreInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Recurrence and Survival in Patients Undergoing Sentinel Lymph Node Biopsy for Merkel Cell Carcinoma: Analysis of 153 Patients from a Single InstitutionAnnals of Surgical Oncology, 2011
- Radiation monotherapy as regional treatment for lymph node‐positive Merkel cell carcinomaCancer, 2010
- Adjuvant Radiation Therapy Is Associated With Improved Survival in Merkel Cell Carcinoma of the SkinJournal of Clinical Oncology, 2007
- Merkel Cell Carcinoma: Improved Outcome With the Addition of Adjuvant TherapyJournal of Clinical Oncology, 2005
- A Meta-analysis of the Prognostic Significance of Sentinel Lymph Node Status in Merkel Cell CarcinomaDermatologic Surgery, 2002
- The Will Rogers PhenomenonNew England Journal of Medicine, 1985